help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wei, S.
Right arrow Articles by Ross, F. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wei, S.
Right arrow Articles by Ross, F. P.
Endocrinology Vol. 142, No. 3 1290-1295
Copyright © 2001 by The Endocrine Society


ARTICLES

Receptor Activator of Nuclear Factor-{kappa}B Ligand Activates Nuclear Factor-{kappa}B in Osteoclast Precursors1

Shi Wei, Steven L. Teitelbaum, Michael W.-H. Wang and F. Patrick Ross

Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110

Address all correspondence and requests for reprints to: F. Patrick Ross, Ph.D., Department of Pathology, Washington University School of Medicine, Barnes-Jewish Hospital North Mail Stop #90–30-669, 216 South Kingshighway, St. Louis, Missouri 63110. E-mail: rossf{at}medicine.wustl.edu

Receptor activator of nuclear factor-{kappa}B ligand [RANK ligand (RANK-L)] stimulates mature osteoclasts to resorb bone, a process associated with NF-{kappa}B activation. RANK-L also prompts macrophages to develop the osteoclast phenotype. Although NF-{kappa}B is essential for osteoclast differentiation, it is not known whether RANK-L activates this transcription complex in osteoclast precursors. We report that RANK-L rapidly induces NF-{kappa}B activation in both authentic osteoclast precursors, namely bone marrow macrophages, and RAW 264.7 cells, a murine macrophage line also capable of RANK-L-mediated osteoclastogenesis. Supershift studies reveal the RANK-L-induced DNA binding moiety contains p50/p65, the most common NF-{kappa}B complex. Subcellular translocation of p50 and p65 subunits is confirmed by Western blots and immunofluorescence analysis. RANK-L activates NF-{kappa}B in both bone marrow macrophages and RAW 264.7 cells by serine phosphorylation of I{kappa}B{alpha} within 5 min, resulting in rapid I{kappa}B{alpha} degradation and resynthesis. Attesting to function, RANK-L treatment of RAW 264.7 cells transiently transfected with a plasmid containing NF-{kappa}B consensus elements linked to luciferase greatly enhances reporter activity. Our data suggest that activation of the NF-{kappa}B pathway is an integral component of RANK-L-induced osteoclast differentiation.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2001 by The Endocrine Society